InsidersTradesSigma
Diamyd Medical AB: directors' dealings · Finland · FIN-FSA
FI:diamyd-medical-abSE0024467914FI·FIN-FSAMcap 166M€Healthcare
Explore the full directors' dealings record of Diamyd Medical AB, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Diamyd Medical AB has recorded 5 reports. Market capitalisation: €166.4m. The latest transaction was reported on 5 May 2025 — Purchase. Among the most active insiders: Anders Essen-Möller. The full history is free.
5
Insider Decl.
0
Thresholds
€568,664
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
1.21 €
Analyst consensus
1 analystsStrong buy
1.55 €Target 1.55 €(+28%)1.55 €
Income statement
Revenue130 k€
Gross profit−3.7 M€-2850% margin
Net income−169.8 M€-130597.7% margin
Valuation
PER (forward)-1.6x
P/Book1.0x
Beta2.33
Balance sheet & cash
Market cap166.4 M€
Total debt30.7 M€
Free Cash Flow−137.2 M€
Profitability & ownership
ROE-142.5%
ROA-60.0%
% insiders23.0%
% institutions6.3%
Last declaration on 5 May 2025
Declarations5 total
Executives●Purchase34FIN-FSA
€9051,000 shares@ €0.90490.0005% mcap100.0% of flow
BTU (betald tecknad unit)
FI:A003N869-1·
Ideal exit: 30 Jan 2026 (T+270)
Executives●Purchase19FIN-FSA
€7421,020 shares@ €0.72770.0004% mcap100.0% of flow
BTU (betald tecknad unit)
FI:A003N791-1·
Ideal exit: 24 Jan 2026 (T+270)
Executives●Purchase22FIN-FSA
€239,277327,124 shares@ €0.73150.14% mcap42.9% of flow
BTU (betald tecknad unit)
FI:A003N796-1·
Ideal exit: 25 Jan 2026 (T+270)
Executives●Purchase25FIN-FSA
€318,644435,630 shares@ €0.73150.19% mcap57.1% of flow
BTU (betald tecknad unit)
FI:A003N795-1·
Ideal exit: 25 Jan 2026 (T+270)
Executives●Purchase19FIN-FSA
€9,09612,500 shares@ €0.72770.0055% mcap100.0% of flow
BTU (betald tecknad unit)
FI:A003N704-1·
Ideal exit: 24 Jan 2026 (T+270)
5 of 5 declarations